Kevin F. Mclaughlin - 10 Oct 2022 Form 4 Insider Report for Decibel Therapeutics, Inc.

Role
Director
Signature
Jeffrey W. Schulz, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
10 Oct 2022
Net transactions value
$0
Form type
4
Filing time
12 Oct 2022, 08:23:31 UTC
Previous filing
29 Apr 2022
Next filing
28 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DBTX Stock Option (right to buy) Award $0 +20,000 $0.000000 20,000 10 Oct 2022 Common Stock 20,000 $2.88 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on October 10, 2022 for 20,000 shares. The shares underlying the option vest in equal monthly installments until the third anniversary of the grant date, subject to the reporting person's continued service.